Remidex Pharma Private Limited, a active private limited company, was established on 15 June 1981 in Bengaluru, Karnataka, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24231KA1981PTC004260. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹3.00 Cr and a paid-up capital of ₹3.00 Cr.
It upholds a compliant status. Employing 123 professional, Its leadership includes Ishaan Pejavar Rao (Director), Nandan Pejavar Rao (Director), Nilima Dayanand Rao (Managing Director). Past directors included Seegakula Sathyanarayana Setty, Namagundlu Bhaskarasastry Vishwanath, Venkatram Subramony. It holds ₹4.00 Cr open charges and ₹15.26 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at B-249,250,147&148, 6Th Main 2Nd Stage, Peenya Industrial Estate, Bengaluru, Karnataka, 560058.
U24231KA1981PTC004260
004260
15 June 1981
₹3.00 Cr
₹3.00 Cr
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Remidex Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ishaan Pejavar Rao | Director | 24 Oct 2018 | Current |
| Nandan Pejavar Rao | Director | 24 Oct 2018 | Current |
| Nilima Dayanand Rao | Managing Director | 24 Jan 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 18 May 2011 | Past |
| Pramod Abcsdd | Director | 31 Oct 2008 | Past |
| Pramod Abcsdd | Director | 22 Dec 2018 | Past |
| Pramod Abcsdd | Director | 11 Jun 2020 | Past |
| Pramod Abcsdd | Director | 05 Dec 2018 | Past |
| Pramod Abcsdd | Director | 29 Oct 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Remidex Pharma Private Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 0.34% increase. The company also saw a substantial improvement in profitability, with a 41.79% increase in profit. The company's net worth observed a substantial decline by a decrease of 42.1%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Remidex Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹40,000,000.00
₹152,550,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Apr 2006 | Canara Bank | ₹4.00 Cr | Open |
| 21 Aug 2019 | Others | ₹6.00 Cr | Satisfied |
| 20 Jul 2018 | Canara Bank | ₹3.10 M | Satisfied |
| 29 Jan 2005 | Kotak Mahindra Bank Ltd | ₹1.95 Cr | Satisfied |
| 29 Jan 2005 | Kotak Mahindra Bank Limited | ₹3.35 Cr | Satisfied |
Explore comprehensive loan charge details -
Remidex Pharma has a workforce of 123 employees as of Mar 21, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Remidex Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Remidex Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Remidex Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.
The activity A charge with Canara Bank of Rs. 4.00 Cr registered on 16 Apr 2006 with Charge ID 80047323 was modified on 09 Sep 2025. was completed.
The activity Remidex Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore. was completed.
The activity A charge registered on 20 Jul 2018 via Charge ID 100241950 with Canara Bank was fully satisfied on 20 Jan 2022. was completed.
The activity A charge registered on 16 May 1998 via Charge ID 90191951 with Canara Bank was fully satisfied on 19 Jun 2020. was completed.
Progress on A charge registered on 14 Nov 1997 via Charge ID 90191869 with Canara Bank was fully satisfied on 19 Jun 2020. was documented.
The CIN of Remidex Pharma Private Limited is U24231KA1981PTC004260.
Remidex Pharma Private Limited is headquartered at B-249,250,147&148, 6Th Main 2Nd Stage, Peenya Industrial Estate, Bengaluru, Karnataka, 560058.
Remidex Pharma Private Limited was incorporated on 15 June 1981.
The current directors of Remidex Pharma Private Limited are
The primary industry of Remidex Pharma Private Limited is Manufacturing.
Remidex Pharma Private Limited is unlisted.
The authorized capital of Remidex Pharma Private Limited is ₹3.00 Cr, and the paid-up capital is ₹3.00 Cr.
The compliance status of Remidex Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX